Pivotal trial of reovirus in patients with locoregionally recurrent or distally metastatic squamous cell carcinoma of the head and neck.

Trial Profile

Pivotal trial of reovirus in patients with locoregionally recurrent or distally metastatic squamous cell carcinoma of the head and neck.

Planning
Phase of Trial: Phase III

Latest Information Update: 08 Oct 2012

At a glance

  • Drugs Pelareorep (Primary)
  • Indications Head and neck cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top